HCV, HBV, HIV Testing During Consultation With Anesthesiologist

NCT04286347 | Terminated

• 2 other identifiers: APHP1911142019-A03071-56
• Study Type: interventional
• Target: 363
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of the study is to assess the feasibility of HCV, HBV, HIV testing (according to the national guidelines) during consultation with Anesthesiologist before a planned surgery in Lariboisiere Hospital, Paris, France. The feasibility will be the number of tested patients divided by the number of patients who should have been tested according to the national guidelines (for each virus).

Conditions

HCV; HBV; Hiv

Outcome Measures

Primary Outcomes (1)

• Feasibility of HCV, HBV, HIV testing

  Feasibility (assessed by the number of tested patients divided by the number of patients who should have been tested according to the national guidelines (for each virus)) of HCV, HBV, HIV testing during consultation with Anesthesiologist before a planned surgery in Lariboisiere Hospital, Paris, France

  Day 0 : during initial consultation, up to 1 hour

Secondary Outcomes (2)

• Acceptability of HCV, HBV, HIV testing

  Day 0 : during initial consultation, up to 1 hour

• Acceptability of being treated (for each virus) for the patients who have been tested positive for HCV and/or HBV and/or HIV, by questionning

  during Day 0, after the initial consultation

Study Arms (1)

HCV, HBV, HIV testing

EXPERIMENTAL

All patient ≥ 18 years-old with a next planned surgery in Lariboisiere Hospital, Paris, France, able to give written informed consent for testing will be proposed to be tested for HIV and HCV if no previous testing found in the medical record and will be proposed to be tested for HBV if the patient belong to a high-risk group: high prevalence area (Asia, sub-Saharan Africa, French Indies, East and South Europe, North-Africa, Middle-East, India, Pakistan, South-America), IVDU, prisoners, unprotected sexual intercourses.

Procedure: HCV, HBV, HIV tests

Interventions

HCV, HBV, HIV tests PROCEDURE

HCV, HBV, HIV testing during consultation with Anesthesiologist before a planned surgery

HCV, HBV, HIV testing

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• patient ≥ 18 years-old
• planned surgery in Lariboisiere Hospital, Paris, France
• able to give written informed consent for testing
• proposed to be tested for HIV and HCV if no previous testing found in the medical record
• proposed to be tested for HBV if the patient belong to a high-risk group: high prevalence area (Asia, sub-Saharan Africa, French Indies, East and South Europe, North-Africa, Middle-East, India, Pakistan, South-America), IVDU, prisoners, unprotected sexual intercourses.

You may not qualify if:

• patient \< 18 years-old
• emergency surgery
• unable to give written informed consent for testing: psychiatric diseases, neurologic diseases, …
• a previous testing for HIV and HCV found in the medical record and no obvious risk factor after previous testing
• the patient does not belong to a high-risk group for HBV

Sponsors & Collaborators

• Assistance Publique - Hôpitaux de Paris: lead
• Gilead Sciences: collaborator

Study Sites (1)

Lariboisière

Paris, 75475, France

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Interventions

HIV Testing

Condition Hierarchy (Ancestors)

HIV Infections; Blood-Borne Infections; Communicable Diseases; Infections; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Lentivirus Infections; Retroviridae Infections; RNA Virus Infections; Virus Diseases; Slow Virus Diseases; Genital Diseases; Urogenital Diseases; Immunologic Deficiency Syndromes; Immune System Diseases

Intervention Hierarchy (Ancestors)

Microbiological Techniques; Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Investigative Techniques

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 17, 2020
• First Posted: February 27, 2020
• Study Start: August 5, 2021
• Primary Completion: October 27, 2021
• Study Completion: October 27, 2021
• Last Updated: December 2, 2021

Record last verified: 2021-11

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)